Theophylline

Safety, Warnings & Patient Protection (Canada)

Basic Theophylline Information

• INN (International Nonproprietary Name): not specified
• Brand Names Available In Canada (English): not specified
• ATC Code: not specified
• Forms & Dosages: not specified
• Manufacturers In Canada (English): not specified
• Registration Status In Canada (English): not specified
• OTC / Rx Classification: not specified

Notify your prescriber or pharmacist before starting if you are pregnant, breastfeeding, elderly, or have limited access to monitoring.

Tell clinicians about known cardiac arrhythmias, seizure disorder, significant liver disease, or heavy alcohol use.

Because plasma concentrations can be close to toxic levels, arrange baseline and follow‑up therapeutic drug monitoring.

If you have cardiac history, request an ECG before treatment changes.

• Before You Start Checklist:
• Allergies to methylxanthines or excipients.
• Complete drug list including antibiotics and antidepressants.
• Smoking status and recent cessation plans.
• Pregnancy test if applicable.

• TDM Terms
• Trough Level — concentration immediately before next dose.
• Therapeutic Range — usual target range for symptom control and safety.
• Steady State — when plasma levels are stable after dose change.

High-Risk Groups (Elderly, Pregnant, Indigenous Health Considerations)

Elderly patients often require lower starting doses and closer therapeutic drug monitoring.

Pregnancy alters clearance so increased monitoring and specialist input are appropriate.

For Indigenous patients in remote communities, plan blood draws and ECG access before prescribing.

Document follow-up arrangements and consider local nursing or community health services for monitoring.

Interaction With Activities (Driving, Machinery, Workplace Safety Under Canadian Law)

Avoid driving or operating heavy machinery if you feel dizzy, excessively tremulous, or experience palpitations.

Inform occupational health when treatment could cause abrupt symptoms that increase workplace risk.

Consider temporary duty modifications until dose and tolerability are confirmed by therapeutic drug monitoring.

Q&A: “Can I Drive After Taking It In Canada?”

Short answer: Only if you feel alert and free of side effects such as dizziness, palpitations or confusion.

If your dose was recently changed or levels are being monitored, exercise caution until the medication is tolerated.

Usage Basics For Canadians

This section explains how theophylline is typically presented and handled in Canada.

• Common Canadian brand and generic searches include names like Uniphyl, Theo-Dur, Theolair and AA‑THEO LA for extended‑release products.
• Theophylline is generally a prescription medication in Canadian practice and not an over‑the‑counter option.
• Verify the DIN and product monograph on the Health Canada Drug Product Database before prescribing or dispensing.

Legal classification: prescription-only medication with provincial dispensing rules that require documented monitoring.

• Pharmacist Counselling Points Checklist:
• Confirm smoking status and planned cessation.
• Review current antibiotics, antidepressants and antiseizure drugs.
• Arrange baseline TDM and ECG if cardiac history exists.
• Explain the importance of not crushing extended‑release tablets.

Note: Some provinces expect bilingual labelling on packaging and patient information leaflets.

Canadian Dosing Guide

Dosing must be individualised and guided by therapeutic drug monitoring.

Typical therapeutic plasma concentration targets commonly aim for approximately 5–15 mg/L, though local lab ranges vary.

• Measure a trough level 3–5 days after initiation or a dose adjustment to assess steady state.
• Recheck levels whenever interacting medications are started or stopped.
• Adjust maintenance dosing to achieve symptom control with the lowest effective plasma concentration.

Adult extended‑release starting doses vary by weight and indication and should be calculated by the prescriber with pharmacist input.

Paediatric dosing is weight‑based and usually specialist‑directed, especially for neonates and premature infants.

• Dosing Checks:
• Confirm renal and hepatic function prior to starting.
• Reduce starting dose for hepatic impairment or congestive heart failure.
• Expect increased monitoring and possible dose reduction during pregnancy.
• Anticipate lower initial doses in frail elderly patients.

Q&A: “What If I Miss A Dose Under My Provincial Drug Plan?”

Short answer: If a dose is missed, take it as soon as remembered unless it is near the next scheduled dose; do not double up.

If insurance or plan limits risk a gap, contact the prescriber or pharmacist for a bridging prescription rather than changing dosing on your own.

Interaction Chart (Canadian Context)

Theophylline is mainly metabolised by CYP1A2, so many drugs and lifestyle factors alter clearance and concentrations.

• Common OTC Interactions:
• Some cough medicines and cold products with caffeine can worsen side effects.
• Herbal products like St. John’s wort may alter levels through enzyme induction.
• Ask your pharmacist before using new OTC medicines while on theophylline.

• When To Check Levels Checklist:
• After starting or stopping interacting antibiotics or anticonvulsants.
• After smoking cessation or initiation.
• When symptoms of toxicity or lack of effect appear.

User Reports & Trends In Canada

Patients in Canadian forums commonly report insomnia, tremor and stomach upset when taking theophylline.

Many patients express frustration with frequent blood tests and dose adjustments required for safe therapy.

Pharmacists note adherence challenges when multiple dose changes and monitoring appointments are needed.

Clinical trend: routine use for asthma has declined as inhaled controllers and biologic therapies have become standard.

Theophylline remains an adjunct for selected COPD patients and in settings where inhaled therapy or biologics are not accessible or affordable.

• Top Patient Complaints:
• Insomnia and tremor interfering with sleep.
• Frequent clinic visits and blood draws.
• Uncertainty when antibiotics are prescribed.

Pharmacovigilance: report suspected adverse reactions to your pharmacy and to Health Canada’s Canada Vigilance Program.

• Checklist For Suspected Toxicity:
• Note symptoms, timing relative to dose, recent new medications and smoking changes.
• Bring this information to your prescriber or pharmacist when reporting.

Access & Purchase Options In Canada

In Canada, theophylline is typically dispensed by retail chains and hospital pharmacies with a valid prescription.

Major chains include Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu where prescriptions can be filled and monitoring arranged.

Licensed online pharmacies may supply theophylline if they verify a prescription and operate under provincial regulations.

Cross‑border or unverified online purchases carry a risk of counterfeit or unregulated products and are not recommended.

• What To Bring For First Fill:
• Valid prescription and government ID.
• Complete medication list and smoking history.
• Contact details for the prescriber and arranged lab scheduling.

In our online pharmacy, theophylline is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Mechanism & Pharmacology (Patient & Clinical)

How does it work: theophylline relaxes airway smooth muscle and reduces breathlessness.

At a clinical level the drug acts as a phosphodiesterase inhibitor and an adenosine receptor antagonist, raising intracellular cAMP.

These effects produce bronchodilation and modest anti‑inflammatory actions.

• Pharmacokinetics Factors Affecting Dosing:
• Age — children and neonates clear the drug differently from adults.
• Smoking — induces CYP1A2 and increases clearance.
• Liver disease — reduces clearance and requires dose reduction.
• Drug interactions — CYP1A2 inhibitors raise levels; inducers lower them.

Extended‑release preparations produce more stable plasma concentrations and reduce peak‑trough fluctuations.

Indications & Off‑Label Uses In Canada

Approved roles: adjunctive therapy for chronic asthma where inhaled therapies are insufficient and for select COPD patients.

Hospital formularies vary and prescribers should confirm product monograph and DIN when ordering.

• Off‑Label Documentation Checklist:
• Document indication, informed consent discussion and monitoring plan.
• Record alternative therapies considered and reason for choosing theophylline.

Key Clinical Findings & Safety Monitoring (2022–2025 Focus)

Recent guidance reinforces a limited role for theophylline versus inhaled controllers due to variable benefit and increased adverse events at higher concentrations.

Consensus continues to stress therapeutic drug monitoring and careful patient selection.

• Recommended Baseline Tests:
• Liver function tests if liver disease suspected.
• ECG for patients with cardiac history.
• Baseline theophylline trough level if clinically indicated.

Clinicians should report serious adverse drug reactions to Canada Vigilance and review alerts on interacting agents.

Alternatives Matrix

Compare therapies with documented DINs in Canada when considering switching from theophylline.

• Switching Steps Checklist:
• Plan tapering or overlap to avoid loss of control.
• Arrange spirometry and follow-up therapeutic monitoring as appropriate.
• Document reasons and patient consent for the change.

Common Questions From Canadian Patients

• How Will I Know If The Dose Is Right? — Symptom control plus a therapeutic blood level without side effects such as tremor or insomnia.
• How Often Are Blood Tests? — Typically after initiation or dose changes, then periodically based on stability and interacting medications.
• Is It Safe In Pregnancy? — Use only if benefits outweigh risks; discuss with obstetric care and arrange closer monitoring.
• Can I Stop Smoking While On Therapy? — Inform your prescriber first; smoking cessation reduces clearance and can raise levels so prompt TDM and a dose reduction may be needed.

A printable one‑page Q&A for clinics and pharmacies helps patients remember when to seek care and when to check levels.

Coverage & Purchase Comparison

Province Coverage Table Recommendation

Step‑By‑Step Purchase Checklist For Canadian Patients

1. Bring a valid prescription with indication documented.
2. Bring government ID and disclose smoking history.
3. Ask the pharmacist to confirm DIN and whether brand substitution is allowed.
4. Confirm the monitoring plan including lab dates and ECG if needed.
5. Apply for special authorisation through your provincial plan if required.

Registration & Regulation

• Health Canada: verify approval status through the Drug Product Database and read the product monograph for DIN and labelled indications.
• Ensure packaging and patient information meet bilingual labelling requirements where applicable.
• Pharmacists must follow provincial dispensing standards and monitor for unsafe regimens.
• Report serious adverse drug reactions to Canada Vigilance.

• Where To Find Key Regulatory Documents:
• Health Canada Drug Product Database for DIN and monograph.
• Provincial college of pharmacists for dispensing standards and contact points.
• Canada Vigilance for adverse reaction reporting forms.

• Prescriber Documentation Checklist For Off‑Label Use:
• Indication, informed consent, monitoring schedule and rationale for choice.

Storage & Handling

Store oral theophylline tablets in a cool, dry place below 25 °C, away from children and pets.

Keep extended‑release tablets in their original packaging and do not crush or split unless explicitly allowed by the product monograph.

Injectable forms, when used in hospital settings, may have product‑specific storage requirements—consult the monograph.

• Home Storage Checklist:
• Store below 25 °C, protect from moisture and heat.
• Keep out of reach of children and pets.
• Do not share medication with others.
• Return unused medication to a pharmacy take‑back program; do not flush.

Guidelines For Proper Use

• Pharmacist Guidance Checklist:
• Verify baseline liver tests and ECG if indicated prior to initiating therapy.
• Arrange the initial therapeutic drug monitoring 3–5 days after starting or changing dose.
• Counsel on interactions with smoking, antibiotics (ciprofloxacin, macrolides) and antidepressants.
• Explain side effects and clear instructions for when to seek urgent care.

Provincial health authorities recommend aligning prescribing with local COPD and asthma formularies and documenting informed consent for off‑label use.

Provide patients with a stamped follow‑up plan in the pharmacy record listing next lab date and contact numbers.

• Printable Patient Plan Template Items:
• Emergency symptoms (severe vomiting, seizure, severe palpitations).
• When to phone the pharmacist or prescriber.
• Steps if a dose is missed or if starting/stopping an interacting medication.

Delivery Across Canada (English)